Missing cohort: Inflammatory bowel disease patients at increased risk for cervical dysplasia may be undervaccinated for HPV

Inflammatory Bowel Diseases

Volumn 18, Issue 4, 2012, Pages 797-

  Al Bawardy, Badr ^a   Fine, Sean ^a   LaFond, Jeffrey ^a   Doran, Amy ^a   Borum, Marie L ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

AGE DISTRIBUTION; ENTERITIS; HUMAN; LETTER; PAPANICOLAOU TEST; PATIENT CARE; PATIENT COUNSELING; PHYSICIAN; PRIORITY JOURNAL; RISK FACTOR; UTERINE CERVIX DYSPLASIA; VACCINATION; WART VIRUS;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; PAPILLOMAVIRUS VACCINES; RISK; UNITED STATES; UTERINE CERVICAL DYSPLASIA; YOUNG ADULT;

EID: 84858707648     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21660     Document Type: Letter

References (3)

1. Insinga RP, Glass AG, Rush BB. Diagnoses and outcomes in cervical cancer screening: a population-based study. Am J Obstet Gynecol. 2004;191:105-113. (Pubitemid 39077962)
2. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal Pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2008;103:631-636. (Pubitemid 351405963)
3. FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med. 2007;356:1915-1927.